ImmunityBio, Inc.

ImmunityBio, Inc.verified

IBRX

Price:

$2.3

Market Cap:

$2.26B

ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amy...[Read more]

Industry

Biotechnology

IPO Date

2015-07-28

Stock Exchange

NASDAQ

Ticker

IBRX

The Enterprise Value as of December 2025 (TTM) for ImmunityBio, Inc. (IBRX) is 2.24B

According to ImmunityBio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.24B. This represents a change of -12.26% compared to the average of 2.56B of the last 4 quarters.

ImmunityBio, Inc. (IBRX) Historical Enterprise Value (quarterly & annually)

How has IBRX Enterprise Value performed in the past?

The mean historical Enterprise Value of ImmunityBio, Inc. over the last ten years is 2.69B. The current 2.24B Enterprise Value has changed 8.26% with respect to the historical average. Over the past ten years (40 quarters), IBRX's Enterprise Value was at its highest in in the March 2021 quarter at 9.36B. The Enterprise Value was at its lowest in in the December 2018 quarter at 367.14M.

Quarterly (TTM)
Annual

Average

2.69B

Median

2.54B

Minimum

367.14M

Maximum

5.48B

ImmunityBio, Inc. (IBRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ImmunityBio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 295.38%

Maximum Annual Enterprise Value = 5.48B

Minimum Annual Increase = -73.83%

Minimum Annual Enterprise Value = 367.14M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20242.43B-19.34%
20233.01B13.90%
20222.65B-6.52%
20212.83B-47.07%
20205.35B268.45%
20191.45B295.38%
2018367.14M-73.83%
20171.40B-25.36%
20161.88B-65.71%
20155.48B-49.61%

ImmunityBio, Inc. (IBRX) Average Enterprise Value

How has IBRX Enterprise Value performed in the past?

The current Enterprise Value of ImmunityBio, Inc. (IBRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.70B

5-year avg

3.25B

10-year avg

2.69B

ImmunityBio, Inc. (IBRX) Enterprise Value vs. Peers

How is IBRX’s Enterprise Value compared to its peers?

ImmunityBio, Inc.’s Enterprise Value is less than Arcus Biosciences, Inc. (2.59B), less than Denali Therapeutics Inc. (2.90B), greater than 89bio, Inc. (2.11B), less than Cogent Biosciences, Inc. (5.53B), greater than Galapagos N.V. (1.72B), less than Beam Therapeutics Inc. (2.82B), greater than Recursion Pharmaceuticals, Inc. (1.53B), less than Liquidia Corporation (2.94B), greater than Agios Pharmaceuticals, Inc. (1.55B), less than Viridian Therapeutics, Inc. (2.54B),

Build a custom stock screener for ImmunityBio, Inc. (IBRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmunityBio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmunityBio, Inc. (IBRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmunityBio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is ImmunityBio, Inc.'s Enterprise Value?

What is the highest Enterprise Value for ImmunityBio, Inc. (IBRX)?

What is the 3-year average Enterprise Value for ImmunityBio, Inc. (IBRX)?

What is the 5-year average Enterprise Value for ImmunityBio, Inc. (IBRX)?

How does the current Enterprise Value for ImmunityBio, Inc. (IBRX) compare to its historical average?